Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force
- PMID: 12558362
- DOI: 10.7326/0003-4819-138-3-200302040-00015
Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force
Abstract
Background: Type 2 diabetes mellitus is associated with a heavy burden of suffering. Screening for diabetes is controversial.
Purpose: To examine the evidence that screening and earlier treatment are effective in reducing morbidity and mortality associated with diabetes.
Data sources: MEDLINE, the Cochrane Library, reviews, and experts, all of which addressed key questions about screening.
Study selection: Studies that provided information about the existence and length of an asymptomatic phase of diabetes; studies that addressed the accuracy and reliability of screening tests; and randomized, controlled trials with health outcomes for various treatment strategies were selected.
Data extraction: Two reviewers abstracted relevant information using standardized abstraction forms and graded articles according to U.S. Preventive Services Task Force criteria.
Data synthesis: No randomized, controlled trial of screening for diabetes has been performed. Type 2 diabetes mellitus includes an asymptomatic preclinical phase; the length of this phase is unknown. Screening tests can detect diabetes in its preclinical phase. Over the 10 to 15 years after clinical diagnosis, tight glycemic control probably reduces the risk for blindness and end-stage renal disease, and aggressive control of hypertension, lipid therapy, and aspirin use reduce cardiovascular events. The magnitude of the benefit is larger for cardiovascular risk reduction than for tight glycemic control. The additional benefit of starting these treatments in the preclinical phase, after detection by screening, is uncertain but is probably also greater for cardiovascular risk reduction.
Conclusions: The interventions that are most clearly beneficial during the preclinical phase are those that affect the risk for cardiovascular disease. The magnitude of additional benefit of initiating tight glycemic control during the preclinical phase is uncertain but probably small.
Comment in
-
Summaries for patients. Screening adults for type 2 diabetes mellitus: recommendations from the U.S. Preventive Services Task Force.Ann Intern Med. 2003 Feb 4;138(3):I-52. doi: 10.7326/0003-4819-138-3-200302040-00005. Ann Intern Med. 2003. PMID: 12558380 No abstract available.
-
Translating "tight control"?Ann Intern Med. 2004 Nov 16;141(10):822; author reply 822-3. doi: 10.7326/0003-4819-141-10-200411160-00022. Ann Intern Med. 2004. PMID: 15545688 No abstract available.
Similar articles
-
Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force.Ann Intern Med. 2015 Jun 2;162(11):765-76. doi: 10.7326/M14-2221. Ann Intern Med. 2015. PMID: 25867111 Review.
-
Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force.Ann Intern Med. 2008 Jun 3;148(11):855-68. doi: 10.7326/0003-4819-148-11-200806030-00008. Ann Intern Med. 2008. PMID: 18519931 Review.
-
Screening for Type 2 Diabetes Mellitus [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2003 Feb. Rockville (MD): Agency for Healthcare Research and Quality (US); 2003 Feb. PMID: 20722114 Free Books & Documents. Review.
-
Screening for Chronic Obstructive Pulmonary Disease: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr. Report No.: 14-05205-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr. Report No.: 14-05205-EF-1. PMID: 27170970 Free Books & Documents. Review.
-
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. PMID: 30354042 Free Books & Documents. Review.
Cited by
-
Factors influencing optimal diabetes care and clinical outcomes in Thai patients with type 2 diabetes mellitus: a multilevel modelling analysis.BMJ Open. 2024 May 3;14(5):e079415. doi: 10.1136/bmjopen-2023-079415. BMJ Open. 2024. PMID: 38702083 Free PMC article.
-
Control and complications of diabetes in urban primary care units in Thailand: a cross-sectional study.BMC Prim Care. 2022 Aug 22;23(1):212. doi: 10.1186/s12875-022-01823-7. BMC Prim Care. 2022. PMID: 35996081 Free PMC article.
-
Early detection of type 2 diabetes in socioeconomically disadvantaged areas in Stockholm - comparing reach of community and facility-based screening.Glob Health Action. 2020 Dec 31;13(1):1795439. doi: 10.1080/16549716.2020.1795439. Glob Health Action. 2020. PMID: 32746747 Free PMC article.
-
Screening for type 2 diabetes mellitus.Cochrane Database Syst Rev. 2020 May 29;5(5):CD005266. doi: 10.1002/14651858.CD005266.pub2. Cochrane Database Syst Rev. 2020. PMID: 32470201 Free PMC article.
-
A combination of process of care and clinical target among type 2 diabetes mellitus patients in general medical clinics and specialist diabetes clinics at hospital levels.BMC Health Serv Res. 2017 Aug 7;17(1):533. doi: 10.1186/s12913-017-2486-7. BMC Health Serv Res. 2017. PMID: 28784176 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical